Herpes zoster after liver transplantation: Incidence, risk factors, and complications

Liver Transplantation

Volumn 10, Issue 9, 2004, Pages 1140-1143

  Ignacio Herrero, J ^a   Quiroga, Jorge ^a   Sangro, Bruno ^a   Pardo, Fernando ^a   Rotellar, Fernando ^a   Alvarez Cienfuegos, Javier ^a   Prieto, Jesus ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CYCLOSPORIN A; FAMCICLOVIR; GANCICLOVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; AGE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; GRAFT REJECTION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HERPES ZOSTER; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; LATENT VIRUS INFECTION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTHERPETIC NEURALGIA; POSTOPERATIVE COMPLICATION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RECIPIENT; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; VARICELLA ZOSTER VIRUS; VIRUS REACTIVATION;

FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; INCIDENCE; LIVER CIRRHOSIS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; VIRUS ACTIVATION;

EID: 4544309357     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20219     Document Type: Article

References (11)

1. Gnann JW, Whitley RJ. Herpes zoster. N Engl J Med 2002;347: 340-346.
2. Gourishankar S, McDermid JC, Jhangri GS, PreiksaitisJK. Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era. Am J Transplant 2004;4:108-115.
3. Gnann JW. Other herpesviruses: Herpes simplex virus, varicella-zoster virus, human herpes types 6, 7, and 8. In: Transplant Infections, 1st edition. Philadelphia, PA: Lippincott-Raven; 1998:265-286.
4. Kost RG, Strauss SE. Postherpetic neuralgia: Pathogenesis, treatment and prevention. N Engl J. Med 1996;335:32-42.
5. Herrero JI, Lucena JF, Quiroga J, Sangro B, Pardo F, Rotellar F, et al. Liver transplant recipients older than 60 years have lower survival and higher incidence of malignancy. Am J Transplant 2003;3:1407-1412.
6. Herrero JI, Quiroga J, Sangro B, Girata M, Gomez-Manero N, Pardo F, et al. Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil. Liver Transpl Surg 1999;5:414-420.
7. Donahue JG, Choo PW, Manson JE, Platt R. The incidence of herpes zoster. Arch Intern Med 1005;155:1605-1609.
8. Ragozzino MW, Melton LJ III, Kurland LT, Chu CP, Perry HO. Population-based study of herpes-zoster and its sequelae. Medicine (Baltimore) 1982;61:310-316.
9. Buchbinder SP, Katz MH, Hessol NA, Liu JY, O'Malley PM, Underwood R, Holmber SD. Herpes zoster and human immunodeficiency virus infection. J Infect Dis 1992;166:1153-1156.
10. Gomez-Manero N, Herrero JI, Quiroga J, Sangro B, Pardo F, Cienfuegos JA, Prieto J. Prognostic model for early acute rejection after liver transplantation. Liver Transpl 2001;7:246-254.
11. Gilden DH, Kleinschmidt-DeMaster BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 2000;342:635-645.